Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

UNBELIEVABLE: 4 | History Defined

Like Eli Lilly, Viking Therapeutics' Oral Weight Loss Drug Disappoints, Stock Tanks

On Tuesday, Viking Therapeutics Inc. (NASDAQ:VKTX) released the much-awaited data from its Phase 2 trial of VK2735 pill, the company’s dual agonist of the glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors.

Benzinga

Top Wall Street Forecasters Revamp Viking Holdings Expectations Ahead Of Q2 Earnings

Viking Holdings Ltd (NYSE:VIK) will release earnings results for the second quarter, before the opening bell on Tuesday, Aug. 19.

Benzinga

Eli Lilly Considering Viking Therapeutics Acquisition? Expert Says 'They're Setting Up For Something BIG' As LLY Issues 40-Year Bond

Eli Lilly And Co.‘s (NYSE:LLY) recent, and highly unusual, issuance of a 40-year bond is fueling speculation that the pharmaceutical giant may be preparing for a major acquisition, with Viking Therapeutics Inc. (NASDAQ:VKTX) emerging as a potential target.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Viking's Oral Obesity Drug Poised To Gain Ground After Eli Lilly's Orforglipron Setback: Analyst

Viking Therapeutics, Inc. (NASDAQ:VKTX) is pressing ahead in the weight-loss drug race with the launch of its Phase 2 VENTURE-Oral trial to test a daily pill version of VK2735 in obese and overweight adults, a move analysts say could position the company to capitalize on Eli Lilly’s recent setback and…

Benzinga

A first look at Viking Mira, the cruise brand’s new £377m ocean ship

Viking Mira is getting ready to welcome cruise passengers from spring 2026

The Independent UK

2 Growth Stocks Wall Street Predicts Will Soar 74% to 159%

With a strong pipeline, these two biotechs are poised for explosive growth.

Barchart

Viking Therapeutics Stock Slides After Company Misses Q2 Earnings Estimates

Viking Therapeutics Inc (NASDAQ:VKTX) shares are falling in Wednesday’s after-hours session after the company reported financial results for the second quarter.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

9 Appliance Brands That Are No Longer Reliable

When you invest in a new appliance, you expect it to last for years. For decades, consumers trusted certain brand names to deliver durability and performance. However, due to corporate mergers, changes in manufacturing, and a focus on cutting costs, many of those once-great brands are no longer a safe…

Grocery Coupon Guide

This Buy-Rated Travel Stock Keeps Cruising to New Highs

Viking Holdings (VIK) shows strong technical momentum and hit a new 52-week high on July 15. The stock has a 100% technical “Buy” signal via Barchart. Shares are up more than 60% in the last year. Fundamentals are robust and analyst sentiment is largely bullish on the cruise and expedition...

Barchart

Viking launches new India river cruises

The river cruise brand is working on a new ship that will sail exclusively in the region

The Independent UK

Randy Moss Pays Justin Jefferson Big Compliment Regarding Legacy Status

From one Vikings legendary receiver to another.

Sports Illustrated

Still American-Made: 5 Appliance Brands Proudly Built in the USA

In a time when so many products are made overseas, it’s refreshing to know some companies are still committed to manufacturing in America. Buying American-made appliance brands not only supports U.S. jobs, but it also often means better quality, easier service, and faster parts replacement. While not every part is…

Clever Dude

3 Biotech Stocks to Watch: Iovance, Neurocrine & Viking

Timing matters with biotech stocks; these three companies offer distinct risk-reward profiles but have upcoming catalysts that could redefine their value

MarketBeat

Government ‘putting its money where its mouth is’ with £200m for Acorn scheme

Energy Secretary Ed Miliband visited the Acorn site in Aberdeenshire as it was confirmed it would get £200 million of development funding.

Evening Standard

Get all your
news in one place.

100's of premium titles.
One news app.

Homes & Gardens

The balcony gardens at this year's Chelsea Flower Show showcased a new wave of possibilities for urban spaces – here are the key trends I spotted

What Chelsea Flower Show 2025 balconies tell us - the aesthetic and ecological shifts driving the new garden frontier

MarketBeat

Viking Holdings Posts Strong Q1, Eyes Growth Ahead

After one year of being publicly traded, VIK stock shows resilience and a positive trend, supported by a loyal customer base and an innovative business model

Sports Illustrated

Minnesota Vikings Fans Get Tattooed to Help Announce Team’s 2025 Schedule

The Vikings found a unique, and permanent, way to release their schedule.

The Independent UK

River cruise choice grows as tour operator Trafalgar enters the market

The choice of river cruises continues to grow, with the popular tour operator to launch cruises from next year

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

2 'Strong Buy' Biotech Growth Stocks With Over 200% Upside Potential

With a strong cash position and a robust pipeline, both growth stocks are poised to generate significant long-term returns.

The Independent UK

Viking unveils latest cruise ship for the Nile River

A new ship is coming to the Nile River – here’s everything you need to know

MarketBeat

3 Consumer Discretionary Stocks to Buy in a Divided Economy

These 3 consumer discretionary stocks cater to consumers who are still spending; analysts agree and continue to raise their price targets for these stocks

Woman & Home

Meghan Markle's high-low kitchen is a masterclass in affordable luxury - shop her chic style here

Meghan Markle's high-low kitchen looks like its packed with expensive Le Creuset and Viking, but I've found some surprisingly affordable accessories in there too

MarketBeat

Viking Therapeutics Stock May Struggle After As-Expected Report

Viking Therapeutics stock is trying to push higher as investors attempt to sort out a report that delivered no real news that investors hadn’t already heard.

MarketBeat

Viking Therapeutics Stock Pops But Struggles to Hold Gains

VKTX stock shot higher after announcing a phase 3 trial for its GLP-1 drug candidate; but investors are concerned about a lack of support in Washington

The Independent UK

Viking’s new hydrogen powered ship promises zero-emission cruises

Viking Libra will launch in 2026

1 … 3 4 5 6

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.